Omnicell Inc
NASDAQ:OMCL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.61
53.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Omnicell Inc
Net Margin
Omnicell Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | US |
| Market Cap | 2.1B USD |
| Net Margin |
-2%
|
| Country | US |
| Market Cap | 36.7B USD |
| Net Margin |
24%
|
| Country | US |
| Market Cap | 31.3B USD |
| Net Margin |
10%
|
| Country | AU |
| Market Cap | 24B AUD |
| Net Margin |
50%
|
| Country | US |
| Market Cap | 10B USD |
| Net Margin |
34%
|
| Country | JP |
| Market Cap | 995.1B JPY |
| Net Margin |
16%
|
| Country | US |
| Market Cap | 5.7B USD |
| Net Margin |
4%
|
| Country | US |
| Market Cap | 5.3B USD |
| Net Margin |
-6%
|
| Country | SE |
| Market Cap | 54.2B SEK |
| Net Margin |
25%
|
| Country | US |
| Market Cap | 2.4B EUR |
| Net Margin |
-4%
|
| Country | CN |
| Market Cap | 16.1B CNY |
| Net Margin |
11%
|
Omnicell Inc
Glance View
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Mountain View, California and currently employs 3,800 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The firm's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The firm's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The firm's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Omnicell Inc's most recent financial statements, the company has Net Margin of -1.7%.
You don't have any saved screeners yet
